Orkla ASA: Update on Orkla India – Filing of Draft Red Herring Prospectus with SEBI
As previously stated, including in connection with the Capital’s Market Update on 28 May 2025, Orkla has been evaluating various structural options for Orkla India Limited (“Orkla India”) to unlock value, including accessing the Indian capital markets.
As a part of this process, Orkla India filed a draft red herring prospectus dated 10 June, 2025 (the “DRHP”) with the Indian capital markets regulator, the Securities and Exchange Board of India (“SEBI”); and BSE Limited and the National Stock Exchange of India Limited (together, the “Indian Stock Exchanges”) in connection with the proposed initial public offering of equity shares of face value INR 1 each (the “Equity Shares”, and the initial public offering by Orkla India as the “Offer”).
The Offer, as described in the DRHP, would comprise an offer for sale of up to 22,843,004 Equity Shares (“Offered Shares”), proposed to be undertaken by Orkla Asia Pacific Pte. Ltd., an indirect wholly owned subsidiary of Orkla ASA, and other eligible shareholders of Orkla India. Orkla Asia Pacific Pte. Ltd. intends to offer up to 20,560,768 Equity Shares, representing approximately 90% of the total number of Offered Shares. The Offered Shares constitute approximately 16.68% of the total number of the issued, subscribed and paid-up share capital of Orkla India.
The Offer is subject to receipt of necessary approvals, including from SEBI, the Indian Stock Exchanges, and the registrar of companies. Following the receipt of requisite approvals, the Offer will be launched within the timelines permitted by law, subject to market conditions and other considerations.
The DRHP is available on the website of Orkla India at https://www.orklaindia.com.
Orkla ASA
Oslo, 11 June 2025
Ref.:
SVP Investor Relations
Annie Bersagel
Tel.: +47 986 03 664
This information is subject to disclosure requirements set out in the Norwegian Securities Trading Act Section 5-12.
DISCLAIMER
Not for distribution in the United States of America, Canada, Australia or Japan or in any other jurisdiction in which such distribution or dissemination would be prohibited by applicable law.
This notice is not being made available in, and is not for release, publication or distribution, directly or indirectly, in whole or in part, in or into the United States of America, Canada, Australia or Japan or any other jurisdiction in which such distribution or dissemination would be prohibited by applicable law. This announcement is for informational purposes only and is not intended, and should not be construed, as an offer of, or a solicitation of an offer to buy, securities in the United States or any other jurisdiction. The securities described herein have not been and will not be registered under the United States Securities Act of 1933 (the U.S. Securities Act), or the laws of any state of the United States, and may not be offered or sold within the United States, except pursuant to an exemption from, or in a transaction not subject to, the registration requirements of the U.S. Securities Act and in compliance with all applicable state laws. There will be no public offering of such securities in the United States.